Helius Medical Technologies Inc (NASDAQ: HSDT) kicked off on Monday, up 26.35% from the previous trading day, before settling in for the closing price of $0.49. Over the past 52 weeks, HSDT has traded in a range of $0.37-$9.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 33.74% over the past five years. While this was happening, its average annual earnings per share was recorded 61.26%. With a float of $3.67 million, this company’s outstanding shares have now reached $3.73 million.
Let’s look at the performance matrix of the company that is accounted for 22 employees. In terms of profitability, gross margin is -6.18%, operating margin of -2590.04%, and the pretax margin is -1764.74%.
Helius Medical Technologies Inc (HSDT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Helius Medical Technologies Inc is 1.48%, while institutional ownership is 2.17%. The most recent insider transaction that took place on Dec 14 ’23, was worth 40,475. In this transaction President and CEO of this company bought 5,000 shares at a rate of $8.10, taking the stock ownership to the 16,512 shares.
Helius Medical Technologies Inc (HSDT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 61.26% per share during the next fiscal year.
Helius Medical Technologies Inc (NASDAQ: HSDT) Trading Performance Indicators
Take a look at Helius Medical Technologies Inc’s (HSDT) current performance indicators. Last quarter, stock had a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.18, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Helius Medical Technologies Inc (HSDT)
Helius Medical Technologies Inc (NASDAQ: HSDT) saw its 5-day average volume 0.19 million, a negative change from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 60.11%. Additionally, its Average True Range was 0.07.
During the past 100 days, Helius Medical Technologies Inc’s (HSDT) raw stochastic average was set at 35.55%, which indicates a significant decrease from 86.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 123.89% in the past 14 days, which was higher than the 119.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5356, while its 200-day Moving Average is $2.0727. Nevertheless, the first resistance level for the watch stands at $0.6935 in the near term. At $0.7697, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8895. If the price goes on to break the first support level at $0.4975, it is likely to go to the next support level at $0.3777. Assuming the price breaks the second support level, the third support level stands at $0.3015.
Helius Medical Technologies Inc (NASDAQ: HSDT) Key Stats
The company with the Market Capitalisation of 2.47 million has total of 3,728K Shares Outstanding. Its annual sales at the moment are 640 K in contrast with the sum of -8,850 K annual income. Company’s last quarter sales were recorded 50 K and last quarter income was -3,690 K.
